When Will Individuals Receive Settlement From Purdue Pharma 2025 Form. Supreme Court’s Verdict on Purdue Pharma Settlement Impact on Opioid Crisis As of March 2025: "$7.4B Deal Nets Purdue More Time… " (Law 360; gated) "Purdue Pharma received approval for more mediation time after telling a judge that it had reached definitive terms on a new $7.4 billion settlement of opioid claims…" Tennessee Attorney General Jonathan Skrmetti confirmed the state's portion will exceed $90 million, distributed over 15 years.
Supreme Court rejects nationwide opioid settlement with OxyContin maker Purdue Pharma from wchstv.com
Purdue Pharma and members of the Sackler family will pay $7.4 billion to resolve claims related to their role in the opioid crisis following a January 25, 2025 settlement announcement Attorney General William Tong today announced a $7.4 billion settlement in principle between states, victims and members of the Sackler family and their company Purdue Pharma, Inc
The settlement in principle adds $1.4 billion more than the prior settlement invalidated by the U.S Oh, Purdue (Purdue's litigation timeline available here) Tennessee Attorney General Jonathan Skrmetti confirmed the state's portion will exceed $90 million, distributed over 15 years.
Purdue Pharma Seeks More Time for Settlement Talks With Sacklers. As of March 2025: "$7.4B Deal Nets Purdue More Time… " (Law 360; gated) "Purdue Pharma received approval for more mediation time after telling a judge that it had reached definitive terms on a new $7.4 billion settlement of opioid claims…" Attorney General Phil Weiser helps secure $7.4 billion from Purdue Pharma and the Sackler family for fueling opioid crisis
What the Supreme Court’s Decision to Hear the Purdue Pharma Case Means The New York Times. Tennessee Attorney General Jonathan Skrmetti confirmed the state's portion will exceed $90 million, distributed over 15 years. HARRISBURG - Attorney General Dave Sunday announced that a bipartisan coalition of states and other parties have reached a $7.4 billion settlement, in principle, with members of the Sackler family and their company Purdue Pharma, Inc., for their role in fueling an opioid.